|
|
|
|
|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
|
Fig. 6. Galntl-1 inhibits the binding of ActR-IIB to type I receptors.
(A) Immunohistochemical staining of transiently transfected Cos-7 cells
for ActR-IIB containing a C-terminal HA-TAG and xGalntl-1 containing a
C-terminal FLAG-TAG. (B) Western blot analyses of stage 11
Xenopus animal cap cells expressing HA-tagged ActR-IIB, Alk-3, Alk-4
and Alk-6 and xGalntl-1. (C) Western blot analyses of transiently
transfected HEK 293T cells expressing HA-tagged xActR-IIB and xGalntl-1 and
incubated overnight in the presence or absence of 2 mM benzyl-GalNAc.
(D) Co-immunoprecipitation of HA-tagged Alk-3, Alk-4 and Alk-6 with
MYC-tagged ActR-IIB in the presence or absence of FLAG-tagged xGalntl-1 from
lysates of transiently transfected HEK 293T cells. (E)
Co-immunprecipitation of Alk-3 with Myc-tagged ActR-IIB or FLAG-tagged BMPR-II
in the presence or absence of untagged xGalntl-1. The binding of BMPR-II to
Alk-3 does not seem to be inhibited by xGAlntl-1. (F)
Co-immunprecipitation of Alk-4-HA with ActR-IIB-Myc in the presence of
xGalntl-1, sGalntl-1 or xGalnt-6. Only xGalntl-1 interfered with the formation
of the heteromeric complex. In all experiments, 10% of the lysates used for
co-immunprecipitation was subjected to direct immunprecipitation and the
quantity of protein analysed by western blotting for the different
epitopes.
|
